Universität zu Köln

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Rinaldetti, Sebastien, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2019). FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer. BJU Int., 123 (1). S. 187 - 197. HOBOKEN: WILEY. ISSN 1464-410X

Worst, Thomas S., Weis, Cleo-Aron, Stoehr, Robert, Bertz, Simone, Eckstein, Markus, Otto, Wolfgang, Breyer, Johannes, Hartmann, Arndt, Bolenz, Christian, Wirtz, Ralph M. and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Sci Rep, 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Breyer, Johannes, Wirtz, Ralph M., Erben, Philipp ORCID: 0000-0002-8279-7636, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Bertz, Simone, Sikic, Danijel, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2018). High CDKN2A/p16 and Low FGFR3 Expression Predict Progressive Potential of Stage pT1 Urothelial Bladder Carcinoma. Clin. Genitourin. Cancer, 16 (4). S. 248 - 259. DALLAS: CIG MEDIA GROUP, LP. ISSN 1938-0682

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp ORCID: 0000-0002-8279-7636, Worst, Thomas S., Stoehr, Robert, Eckstein, Markus, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2018). High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer Immunol. Immunother., 67 (3). S. 403 - 413. NEW YORK: SPRINGER. ISSN 1432-0851

Martini, Thomas, Heinkele, Jakob, Mayr, Roman, Weis, Cleo-Aron, Wezel, Felix, Wahby, Sarah, Eckstein, Markus, Schnoller, Thomas, Breyer, Johannes, Wirtz, Ralph, Ritter, Manuel, Bolenz, Christian and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy. Urol. Oncol.-Semin. Orig. Investig., 36 (12). NEW YORK: ELSEVIER SCIENCE INC. ISSN 1873-2496

Eckstein, Markus, Wirtz, Ralph Markus, Gross-Weege, Matthias, Breyer, Johannes, Otto, Wolfgang, Stoehr, Robert, Sikic, Danijel, Keck, Bastian, Eidt, Sebastian, Burger, Maximilian, Bolenz, Christian, Nitschke, Katja, Porubsky, Stefan ORCID: 0000-0002-7647-7265, Hartmann, Arndt and Erben, Philipp ORCID: 0000-0002-8279-7636 (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. Int. J. Mol. Sci., 19 (11). BASEL: MDPI. ISSN 1422-0067

Breyer, Johannes, Otto, Wolfgang, Wirtz, Ralph M., Wullich, Bernd, Keck, Bastian, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Laible, Mark, Schlombs, Kornelia, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urol.Int., 98 (3). S. 282 - 290. BASEL: KARGER. ISSN 1423-0399

Breyer, Johannes, Wirtz, Ralph M., Otto, Wolfgang, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian C., Stoehr, Robert, Eckstein, Markus, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017). In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Arch., 470 (3). S. 267 - 275. NEW YORK: SPRINGER. ISSN 1432-2307

Breyer, Johannes, Wirtz, Ralph Markus, Otto, Wolfgang, Laible, Mark, Schlombs, Kornelia, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian Christian, Stoehr, Robert, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian and Hartmann, Arndt (2017). Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies. Oncotarget, 8 (40). S. 67684 - 67696. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Breyer, Johannes, Wirtz, Ralph M., Laible, Mark, Schlombs, Kornelia, Erben, Philipp ORCID: 0000-0002-8279-7636, Kriegmair, Maximilian Christian, Stoehr, Robert, Eidt, Sebastian, Denzinger, Stefan, Burger, Maximilian, Hartmann, Arndt and Otto, Wolfgang (2016). ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). Virchows Arch., 469 (5). S. 547 - 553. NEW YORK: SPRINGER. ISSN 1432-2307

Gosenca, Darko, Kellert, Beate, Metzgeroth, Georgia, Haferlach, Claudia, Fabarius, Alice, Schwaab, Juliana, Kneba, Michael, Scheid, Christof, Toepelt, Karin, Erben, Philipp ORCID: 0000-0002-8279-7636, Haferlach, Torsten, Cross, Nicholas C. P., Hofmann, Wolf-Karsten, Seifarth, Wolfgang and Reiter, Andreas (2014). Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms. Gene Chromosomes Cancer, 53 (5). S. 411 - 422. HOBOKEN: WILEY. ISSN 1098-2264

Erben, Philipp ORCID: 0000-0002-8279-7636, Schwaab, Juliana, Metzgeroth, Georgia, Horny, Hans-Peter, Jawhar, Mohamad, Sotlar, Karl, Fabarius, Alice, Teichmann, Martina, Schneider, Sven, Ernst, Thomas, Mueller, Martin C., Giehl, Michelle, Marx, Alexander, Hartmann, Karin ORCID: 0000-0002-4595-8226, Hochhaus, Andreas ORCID: 0000-0003-0626-0834, Hofmann, Wolf-Karsten, Cross, Nicholas C. P. and Reiter, Andreas (2014). The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Ann. Hematol., 93 (1). S. 81 - 89. NEW YORK: SPRINGER. ISSN 1432-0584